Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY
Mizuho Medy Co Ltd
/
Income Statement
/
Selling, General & Administrative

Mizuho Medy Co Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mizuho Medy Co Ltd
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Mizuho Medy Co Ltd
TSE:4595
Selling, General & Administrative
-¥2.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Selling, General & Administrative
-¥374.8B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
-7%
Olympus Corp
TSE:7733
Selling, General & Administrative
-¥495.3B
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
Sysmex Corp
TSE:6869
Selling, General & Administrative
-¥147.9B
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
-6%
Nihon Kohden Corp
TSE:6849
Selling, General & Administrative
-¥92.7B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
-6%
JEOL Ltd
TSE:6951
Selling, General & Administrative
-¥44.4B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-6%

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Intrinsic Value
2 479.48 JPY
Undervaluation 8%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Mizuho Medy Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-2.3B JPY

Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Selling, General & Administrative amounts to -2.3B JPY.

What is Mizuho Medy Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
3%

Over the last year, the Selling, General & Administrative growth was -6%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.